Carla Di Loreto

8.2k total citations · 1 hit paper
150 papers, 6.4k citations indexed

About

Carla Di Loreto is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Carla Di Loreto has authored 150 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 35 papers in Oncology and 29 papers in Cancer Research. Recurrent topics in Carla Di Loreto's work include Breast Cancer Treatment Studies (16 papers), RNA modifications and cancer (12 papers) and HER2/EGFR in Cancer Research (12 papers). Carla Di Loreto is often cited by papers focused on Breast Cancer Treatment Studies (16 papers), RNA modifications and cancer (12 papers) and HER2/EGFR in Cancer Research (12 papers). Carla Di Loreto collaborates with scholars based in Italy, United States and United Kingdom. Carla Di Loreto's co-authors include Carlo Alberto Beltrami, Giuseppe Damante, Jan Kajstura, Piero Anversa, Fabio Puglisi, Federico Quaini, Eugenio Quaini, John C. Reed, G Olivetti and Wei Cheng and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Carla Di Loreto

145 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Apoptosis in the Failing Human Heart

1997 1.4k citations Carla Di Loreto, Carlo Alberto Beltrami et al. profile →

Peers

Countries citing papers authored by Carla Di Loreto

Since Specialization

Citations

This map shows the geographic impact of Carla Di Loreto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carla Di Loreto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carla Di Loreto more than expected).

Fields of papers citing papers by Carla Di Loreto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carla Di Loreto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carla Di Loreto. The network helps show where Carla Di Loreto may publish in the future.

Co-authorship network of co-authors of Carla Di Loreto

This figure shows the co-authorship network connecting the top 25 collaborators of Carla Di Loreto. A scholar is included among the top collaborators of Carla Di Loreto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carla Di Loreto. Carla Di Loreto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ultrasonographic scores and parotid histopathology in Sjögren's disease: challenges in lymphoma identification 2024 ·Clinical and Experimental Rheumatology ·Ivan Giovannini, Maria De Martino, (unknown), Michele Lorenzon, Lorenzo Cereser, Carla Di Loreto, (unknown), Enrico Pegolo, (unknown), Luca Quartuccio	1
2	Machine learning to improve interpretability of clinical, radiological and panel-based genomic data of glioma grade 4 patients undergoing surgical resection 2023 ·Journal of Translational Medicine ·Michele Dal Bo, Maurizio Polano, Tamara Ius, (unknown), (unknown), Ivana Manini, Enrico Pegolo, Daniela Cesselli, Carla Di Loreto, Miran Škrap, Giuseppe Toffoli	7
3	Association between indocyanine green clearance test and ischemic type biliary lesions within one year after orthotopic liver transplantation 2021 ·Gastroenterología y Hepatología ·(unknown), Luigi Vetrugno, (unknown), Riccardo Pravisani, (unknown), Dario Lorenzin, Gian Luigi Adani, (unknown), (unknown), Alessandro Vit, Massimo Sponza, (unknown), Carla Di Loreto, Tiziana Bove, Giovanni Terrosu, Andrea Risaliti, Umberto Baccarani	2
4	Integrated multi-omics analyses on patient-derived CRC organoids highlight altered molecular pathways in colorectal cancer progression involving PTEN 2021 ·Journal of Experimental & Clinical Cancer Research ·Marta Codrich, Emiliano Dalla, Catia Mio, Giulia Antoniali, Matilde Clarissa Malfatti, Stefania Marzinotto, Mariaelena Pierobon, Elisa Baldelli, Carla Di Loreto, Giuseppe Damante, Giovanni Terrosu, Carlo Pucillo, Gianluca Tell	36
5	Mitochondrial apurinic/apyrimidinic endonuclease 1 enhances mtDNA repair contributing to cell proliferation and mitochondrial integrity in early stages of hepatocellular carcinoma 2020 ·BMC Cancer ·(unknown), (unknown), (unknown), Riccardo Pravisani, (unknown), Carla Di Loreto, Umberto Baccarani, Carlo Vascotto	17
6	The miRNA Content of Exosomes Released from the Glioma Microenvironment Can Affect Malignant Progression 2020 ·Biomedicines ·Federica Caponnetto, Emiliano Dalla, Damiano Mangoni, Silvano Piazza, Slobodanka Radović, Tamara Ius, Miran Škrap, Carla Di Loreto, Antonio Paolo Beltrami, Ivana Manini, Daniela Cesselli	21
7	Ultrasound-guided core needle biopsy compared with open biopsy: a new diagnostic approach to salivary gland enlargement in Sjögren’s syndrome? 2020 ·Lara D. Veeken ·Alen Zabotti, Sara Zandonella Callegher, Michele Lorenzon, Enrico Pegolo, Cathryn A. Scott, Alessandro Tel, Ivan Giovannini, Massimo Robiony, Carla Di Loreto, Chiara Zuiani, Salvatore De Vita	23
8	Heterogeneity Matters: Different Regions of Glioblastoma Are Characterized by Distinctive Tumor-Supporting Pathways 2020 ·Cancers ·Ivana Manini, Federica Caponnetto, Emiliano Dalla, Tamara Ius, Giuseppe Maria Della Pepa, Enrico Pegolo, (unknown), Giuseppe La Rocca, Grazia Menna, Carla Di Loreto, Alessandro Olivi, Miran Škrap, Giovanni Sabatino, Daniela Cesselli	25
9	Autophagy and Inflammasome Activation in Dilated Cardiomyopathy 2019 ·Journal of Clinical Medicine ·(unknown), Aneta Aleksova, Michela Bulfoni, (unknown), (unknown), (unknown), (unknown), Maria Chiara Mimmi, Carlo Vascotto, Nicoletta Finato, Sandro Sponga, Ugolino Livi, Miriam Isola, Carla Di Loreto, Rossana Bussani, Gianfranco Sinagra, Daniela Cesselli, Antonio Paolo Beltrami	35
10	Semaphorin-7A on Exosomes: A Promigratory Signal in the Glioma Microenvironment 2019 ·Cancers ·Ivana Manini, Maria Elisabetta Ruaro, Riccardo Sgarra, (unknown), Federica Caponnetto, Tamara Ius, Miran Škrap, Carla Di Loreto, Antonio Paolo Beltrami, Guidalberto Manfioletti, Daniela Cesselli	22
11	BET proteins regulate homologous recombination‐mediated DNA repair: BRCAness and implications for cancer therapy 2018 ·International Journal of Cancer ·Catia Mio, Lorenzo Gerratana, Marco Bolis, Federica Caponnetto, (unknown), (unknown), Carla Di Loreto, Enrico Garattini, Giuseppe Damante, Fabio Puglisi	62
12	MCM5 as a target of BET inhibitors in thyroid cancer cells 2016 ·Endocrine Related Cancer ·Catia Mio, Elisa Lavarone, (unknown), Federica Baldan, Barbara Toffoletto, Cinzia Puppin, Sébastiano Filetti, Cosimo Durante, Diego Russo, (unknown), Antonio Di Cristofano, Carla Di Loreto, Giuseppe Damante	41
13	Size-dependent cellular uptake of exosomes 2016 ·Nanomedicine Nanotechnology Biology and Medicine ·Federica Caponnetto, Ivana Manini, Miran Škrap, Timea Palmai‐Pallag, Carla Di Loreto, Antonio Paolo Beltrami, Daniela Cesselli, Enrico Ferrari	145
14	Metastatic breast cancer and circulating exosomes. Hints from an exploratory analysis 2015 ·Annals of Oncology ·Lorenzo Gerratana, Barbara Toffoletto, Michela Bulfoni, Daniela Cesselli, Antonio Paolo Beltrami, Carla Di Loreto, Marta Bonotto, M. Cinausero, Miriam Isola, Stefania Marzinotto, Alessandro Marco Minisini, (unknown), Mauro Mansutti, Gianpiero Fasola, Fabio Puglisi	7
15	Hormone receptor and human epidermal growth factor receptor 2 status evaluation on ThinPrep specimens from breast carcinoma 2012 ·Cancer Cytopathology ·Enrico Pegolo, (unknown), (unknown), (unknown), Laura Deroma, Carla Di Loreto	20
16	Nucleophosmin is overexpressed in thyroid tumors 2010 ·Biochemical and Biophysical Research Communications ·Annalisa Pianta, Cinzia Puppin, Alessandra Franzoni, Dora Fabbro, Carla Di Loreto, Stefania Bulotta, Marta Deganuto, Igor Paron, Gianluca Tell, Efisio Puxeddu, Sébastiano Filetti, Diego Russo, Giuseppe Damante	45
17	A web-based system for tissue microarray data management 2006 ·Diagnostic Pathology ·Vincenzo Della Mea, (unknown), Maura Pandolfi, Carla Di Loreto	6
18	Topoisomerase IIα and APE/ref-1 are associated with pathologic response to primary anthracycline-based chemotherapy for breast cancer 2004 ·Cancer Letters ·Alessandro Marco Minisini, Carla Di Loreto, Mauro Mansutti, (unknown), Stefano Pizzolitto, Andrea Piga, Fabio Puglisi	21
19	Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma 1998 ·Annals of Oncology ·F Silvestri, Giovanni Barillari, Renato Fanin, F. Salmaso, Corrado Pipan, E Falasca, Fabio Puglisi, Laura Mariuzzi, Francesco Zaja, Laura Infanti, Francesca Patriarca, Anna Candoni, (unknown), Carla Di Loreto, (unknown), Michele Baccarani	37
20	Large core biopsy for diagnostic and prognostic evaluation of invasive breast carcinomas 1996 ·European Journal of Cancer ·Carla Di Loreto, Fabio Puglisi, (unknown), Chiara Zuiani, Gabriele Anania, Vincenzo Della Mea, Carlo Alberto Beltrami	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact